HOME >> MEDICINE >> NEWS
Drug attacks prostate cancer in mouse model by destroying its blood supply

HOUSTON - A medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cancer by cutting off its blood supply, researchers from The University of Texas M. D. Anderson Cancer Center report in the June 7 issue of the Journal of the National Cancer Institute.

Imatinib, known commercially as Gleevec, worked best when combined with the chemotherapy paclitaxel to slash the incidence of bone metastases and the size of tumors in mice injected with a multiple-drug resistant form of prostate cancer. Tumors were found in only 4 of 18 mice treated with the combination, median tumor weight was one tenth of a gram, and the cancer spread to the lymph nodes in three cases. Tumors grew in all 19 control mice, their median tumor weight was 1.3 grams, and all metastasized to the lymph nodes.

This extremely drug-resistant form of the cancer, designed by the research team to emulate the grim clinical reality of prostate cancer that has spread into the bone, successfully warded off the combined medications in lab experiments, said Isaiah J. Fidler, D.V.M., Ph.D., chair of the Department of Cancer Biology and director of the Cancer Metastasis Research Center at M. D. Anderson.

"Why, then, did it work so well in the animal? Because we didn't attack the tumor, we attacked the blood vessels. We target and destroy the vasculature that provides oxygen and nutrients to tumor cells," said Fidler, the paper's senior author.

Fidler and colleagues show in the JNCI paper that imatinib killed tumor-related blood vessel (endothelial) cells by inactivating the platelet-derived growth factor receptors (PDGF-R) on the cell surface. This prevents the receptor's activation either by PDGF binding to it externally or by a signal generated internally by the cell.

Activation of PDGF-R stimulates the birth of new blood vessels, promotes cell division and migration, and inhibits a protective form of cell suicide known as apoptosis, all h
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
6-Jun-2006


Page: 1 2 3

Related medicine news :

1. Cognitive therapy can reduce post-traumatic stress in survivors of terrorist attacks
2. New class of HIV drug attacks previously untargeted enzyme
3. Carnegie Mellon professors question advice for nuclear attacks
4. Lack of guidelines on kidney stone attacks could put travel workers and passengers at risk
5. Custom-made cancer cell attacks
6. Drug reduces unscheduled trips to doctor for childhood asthma attacks
7. Aspirin saves lives of cancer patients suffering heart attacks, despite fears of bleeding
8. Statin users risk heart attacks by dropping treatment or taking low doses
9. Timely treatment of heart attacks: Results from the AMI-QUEBEC Study
10. Panic attacks are linked to poor outcomes for diabetic patients, Group Health study finds
11. Blood cells linked to heart attacks, other inflammatory diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... The Stevie® Awards, organizer ... deadline in the 2019 competition is extended to July 18. The original final ... awards program, The IBAs attract nominations from organizations in more than 70 nations ...
(Date:6/13/2019)... ... June 13, 2019 , ... GlycoMark, Inc. announced a new ... Diabetes Association (ADA) Scientific Sessions 2019 involving the GlycoMark test being used for ... SGLT-2 inhibitors are used to lower glucose levels in patients with diabetes by ...
(Date:6/12/2019)... ... June 12, 2019 , ... Learn how to succeed in ... innovative branding and network with others in this growing field. , What are ... manufacturers and others who are part of the rapidly evolving cannabis industry will ...
(Date:6/12/2019)... , ... June 12, 2019 , ... ... the newest addition to the family of Best Sanitizers’ HACCP Footwear Sanitizing Unit ... processing facilities, nutraceutical plants, pharmaceutical plants, clinical research labs, and clean rooms by ...
(Date:6/11/2019)... ... June 11, 2019 , ... The FSH Society today announced ... government regulators, biopharma companies, and academic thought leaders to discuss the current state ... is the world’s largest research-focused patient advocacy organization for FSHD, a hereditary muscle-damaging ...
Breaking Medicine News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... The National ... NCCN Chemotherapy Order Templates ( NCCN Templates ®) into the CureMD Oncology EHR ... the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). , “The collaboration with ...
(Date:6/6/2019)... ... ... MEDICC (Medical Education Cooperation with Cuba) has deplored the Trump administration’s decision ... more assault on the freedom of Americans, Cuban-Americans and the health and livelihoods of ... Directors. , MEDICC has long stood for open dialogue and cooperation with Cuban ...
(Date:6/6/2019)... ... 05, 2019 , ... Cobb-Vantress, Inc. / Siloam Springs, Arkansas, ... avian influenza virus from replicating in lab-grown chicken cells, suggesting that it may ... The study was funded by Biotechnology and Biological Sciences Research Council with additional ...
Breaking Medicine Technology:
Cached News: